FDA Amends Monograph for Over-the-Counter Topical Antifungal Drug Products

Summary

The Food and Drug Administration (FDA) is issuing a final rule amending the monograph for over-the-counter (OTC) topical antifungal drug products, making a minor change in the indications for these products. This rule is part of the FDA's ongoing review of OTC drug products.